Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
Keywords:
Antiprogrammed cell death protein 1 (anti-PD-1)
Antiprogrammed death-ligand 1 (anti-PD-L1)
Checkpoint inhibitor
Immunotherapy, immunotherapy combinations
Ovarian cancer
Editorial note:
© 2019 American Cancer Society
Citation:
Sánchez-Lorenzo, M. L. (María Luisa); González-Martín, A. (Antonio). "Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?". CA, a Cancer Journal for Clinics. 125 (S24), 2019, 4616 - 4622
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.